Suche
Kategorie
Erscheinungsjahr
2742 Treffer
×
Publikationen
×
2021
×
Johannes Gutenberg-Universität Mainz
×
Rheinland-Pfälzische Technische Universität Kaiserslautern-Landau
×
Universität Koblenz
- Pirlich, Nina; Dutz, Matthias; Wittenmeier, Eva et al.
- Current practice of German anesthesiologists in airway management Results of a national online survey
- ANAESTHESIST. 2021
- Lott, Carsten; Truhlar, Anatolij
- Cardiac arrest in special circumstances
- CURRENT OPINION IN CRITICAL CARE. Bd. 27. H. 6. 2021 S. 642-648
- Lott, Carsten
- Cardiac arrest in special circumstances
- NOTARZT. Bd. 37. H. 04. 2021 S. 205-205
- Geber, C.; Kappis, B.; Baesch, T. et al.
- Pain Prevention in the Primary Care Setting Facts for resident Doctors (vol 35, pg 5, 2021)
- SCHMERZ. Bd. 35. H. 1. 2021 S. 13-13
- Geber, C.; Kappis, B.; Baesch, T. et al.
- Pain prevention in the primary care setting Facts for resident physicians
- SCHMERZ. Bd. 35. H. 1. 2021 S. 5-13
- Munoz-Martinez, Sergio; Sapena, Victor; Forner, Alejandro et al.
- Assessing the impact of COVID-19 on liver cancer management (CERO-19)
- JHEP REPORTS. Bd. 3. H. 3. 2021
- Galle, Peter R.; Finn, Richard S.; Cheng, Ann-Lii et al.
- Assessment of the impact of anti-drug antibodies on PK and clinical outcomes with atezolizumab plus bevacizumab in HCC.
- CANCER RESEARCH. Bd. 81. H. 13. 2021
- Castven, Darko; Czauderna, Carolin; Becker, Diana et al.
- Acquired Resistance to Antiangiogenic Therapies in Hepatocellular Carcinoma Is Mediated by Yes-Associated Protein 1 Activation and Transient Expansion of Stem-Like Cancer Cells
- HEPATOLOGY COMMUNICATIONS. Bd. 6. H. 5. 2021 S. 1140-1156
- Sangro, Bruno; Harding, James J.; Johnson, Matthew et al.
- A phase III, double-blind, randomized study of nivolumab (NIVO) and ipilimumab (IPI), nivo monotherapy or placebo plus transarterial chemoembolization (TACE) in patients with intermediate-stage hepatocellular carcinoma (HCC).
- JOURNAL OF CLINICAL ONCOLOGY. Bd. 39. H. 3. 2021
- Moehler, Markus; Michel, Maurice; Stein, Alexander et al.
- A Phase I dose-escalation study of third-line regorafenib with trifluridine/tipiracil in metastatic colorectal cancer
- FUTURE ONCOLOGY. Bd. 17. H. 25. 2021 S. 3309-3319